Los Angeles Capital Management’s Oyster Point Pharma, Inc. Common Stock OYST Stock Holding History

Los Angeles Capital Management’s Portfolio OYST Stock Details OYST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-13,063	Closed	-$246K	–	1677
2020 Q4	$246K	Buy	13,063 +1,010	+8%	+$21.8K	﹤0.01%	1432
2020 Q3	$254K	Buy	+12,053	New	+$282K	﹤0.01%	1321

Other funds holding OYST

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

IFA

Invus Financial Advisors New York $89.2M AUM 10.79% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

VVA

Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

Los Angeles Capital Management's OYST Position: Q1 2021 in Review

Los Angeles Capital Management sold out of Oyster Point Pharma, Inc. Common Stock (OYST) in Q1 2021, closing a stake of 13,063 shares — an estimated $246K sold.

Los Angeles Capital Management first reported a position in OYST in Q3 2020 and held it in 2 quarters. The position peaked at $254K in Q3 2020. 61 funds tracked by Wall St. Rank hold OYST as of Q1 2021.

Los Angeles Capital Management reported no remaining Oyster Point Pharma, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
Los Angeles Capital Management sold 13,063 Oyster Point Pharma, Inc. Common Stock shares in Q1 2021, an estimated $246K.
Los Angeles Capital Management first reported a position in Oyster Point Pharma, Inc. Common Stock in Q3 2020 and held it in 2 quarters.
Los Angeles Capital Management's Oyster Point Pharma, Inc. Common Stock position peaked at $254K in Q3 2020.
61 funds tracked by Wall St. Rank held Oyster Point Pharma, Inc. Common Stock as of Q1 2021.

Based on Los Angeles Capital Management's 13F filing for Q1 2021, filed 5 May 2021.